DERM-BIOME PHARMACEUTICALS
Company Overview
Social Media Profiles
About Derm-Biome Pharmaceuticals
Description
Based in Vancouver, Derm-Biome Pharmaceuticals is a preclinical biopharmaceutical firm established in 2018. The company specializes in developing innovative topical therapies targeting inflammatory skin diseases and skin cancer, addressing significant unmet medical needs in dermatology and improving skin health through advanced biotechnology.
Specialties
Topical therapies for skin diseases
Innovative treatments for acne
Therapies for inflammatory conditions
Research on skin cancer solutions
Microbiome-based dermatological approaches
Products & Services
Topical therapies for acne
Treatments for eczema
Therapies for atopic dermatitis
Innovations for rosacea
Skin cancer treatments
Contact Information
No contact information available
Competitors & Similar Companies(6)
Amgen
Regeneron Pharmaceuticals
Eli Lilly and Company
Aclaris Therapeutics
Incyte Corporation
Dermavant Sciences
News & Media
Search Terms:
derm-biome pharmaceuticals
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about Derm-Biome Pharmaceuticals
Where is Derm-Biome Pharmaceuticals located?
The headquarter of Derm-Biome Pharmaceuticals is located in Vancouver, British Columbia, Canada
What is the official website of Derm-Biome Pharmaceuticals?
The official website of Derm-Biome Pharmaceuticals is https://www.derm-biomepharmaceuticals.com
What industry does Derm-Biome Pharmaceuticals belong to?
Derm-Biome Pharmaceuticals belongs to the Healthcare Technology, Biotechnology, Pharmaceuticals, Biotechnology and Life Sciences industry.
What are the specialties of Derm-Biome Pharmaceuticals?
Derm-Biome Pharmaceuticals specializes in Topical therapies for skin diseases, Innovative treatments for acne, Therapies for inflammatory conditions, Research on skin cancer solutions, Microbiome-based dermatological approaches.
What products and services is Derm-Biome Pharmaceuticals likely to offer?
Derm-Biome Pharmaceuticals offers Topical therapies for acne, Treatments for eczema, Therapies for atopic dermatitis, Innovations for rosacea, Skin cancer treatments.
Who are the competitors of Derm-Biome Pharmaceuticals?
Competitors of Derm-Biome Pharmaceuticals are Amgen, Regeneron Pharmaceuticals, Eli Lilly and Company, Aclaris Therapeutics, Incyte Corporation, Dermavant Sciences.
What does Derm-Biome Pharmaceuticals do?
Based in Vancouver, Derm-Biome Pharmaceuticals is a preclinical biopharmaceutical firm established in 2018. The company specializes in developing innovative topical therapies targeting inflammatory skin diseases and skin cancer, addressing significant unmet medical needs in dermatology and improving skin health through advanced biotechnology.